Infectious Complications in Pediatric, Adolescent and Young Adult Patients Undergoing CD19-CAR T Cell Therapy

CD19-specific chimeric antigen receptor (CAR) T cell therapy has changed the treatment paradigm for pediatric, adolescent and young adult (AYA) patients with relapsed/refractory B-cell acute lymphoblastic leukemia (B-ALL). However, data on the associated infectious disease challenges in this patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Maron, Gabriela M., Hijano, Diego R., Epperly, Rebecca, Su, Yin, Tang, Li, Hayden, Randall T., Naik, Swati, Karol, Seth E., Gottschalk, Stephen, Triplett, Brandon M., Talleur, Aimee C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8959860/
https://www.ncbi.nlm.nih.gov/pubmed/35356197
http://dx.doi.org/10.3389/fonc.2022.845540

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8959860/
https://www.ncbi.nlm.nih.gov/pubmed/35356197
http://dx.doi.org/10.3389/fonc.2022.845540

Ejemplares similares